169 related articles for article (PubMed ID: 7535899)
1. Ramipril prevents the detrimental sequels of chronic NO synthase inhibition in rats: hypertension, cardiac hypertrophy and renal insufficiency.
Hropot M; Grötsch H; Klaus E; Langer KH; Linz W; Wiemer G; Schölkens BA
Naunyn Schmiedebergs Arch Pharmacol; 1994 Dec; 350(6):646-52. PubMed ID: 7535899
[TBL] [Abstract][Full Text] [Related]
2. Angiotensin II subtype AT1 receptor blockade prevents hypertension and renal insufficiency induced by chronic NO-synthase inhibition in rats.
Hropot M; Langer KH; Wiemer G; Grötsch H; Linz W
Naunyn Schmiedebergs Arch Pharmacol; 2003 Mar; 367(3):312-7. PubMed ID: 12644905
[TBL] [Abstract][Full Text] [Related]
3. Role of kinins and nitric oxide in the antihypertrophic effect of ramipril.
Rhaleb NE; Yang XP; Scicli AG; Carretero OA
Hypertension; 1994 Jun; 23(6 Pt 2):865-8. PubMed ID: 7515854
[TBL] [Abstract][Full Text] [Related]
4. Effects of antihypertensive therapy on blood pressure and renal function in rats with hypertension due to chronic blockade of nitric oxide synthesis.
Erley CM; Rebmann S; Strobel U; Schmidt T; Wehrmann M; Osswald H; Risler T
Exp Nephrol; 1995; 3(5):293-9. PubMed ID: 7583051
[TBL] [Abstract][Full Text] [Related]
5. Assessment of renal dopaminergic system activity in the nitric oxide-deprived hypertensive rat model.
Soares-da-Silva P; Pestana M; Vieira-Coelho MA; Fernandes MH; Albino-Teixeira A
Br J Pharmacol; 1995 Apr; 114(7):1403-13. PubMed ID: 7541690
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of nitric oxide synthase prevents myocardial protection by ramiprilat.
Hartman JC; Kurc GM; Hullinger TG; Wall TM; Sheehy RM; Shebuski RJ
J Pharmacol Exp Ther; 1994 Sep; 270(3):1071-6. PubMed ID: 7523655
[TBL] [Abstract][Full Text] [Related]
7. Sildenafil reduces L-NAME-induced severe hypertension and worsening of myocardial ischaemia-reperfusion damage in the rat.
Rossoni G; Manfredi B; De Gennaro Colonna V; Berti M; Guazzi M; Berti F
Br J Pharmacol; 2007 Mar; 150(5):567-76. PubMed ID: 17245365
[TBL] [Abstract][Full Text] [Related]
8. Angiotensin blockade reverses hypertension during long-term nitric oxide synthase inhibition.
Pollock DM; Polakowski JS; Divish BJ; Opgenorth TJ
Hypertension; 1993 May; 21(5):660-6. PubMed ID: 7684026
[TBL] [Abstract][Full Text] [Related]
9. Persistent hypertension following inhibition of nitric oxide formation in the young Wistar rat: role of renin and vascular hypertrophy.
Morton JJ; Beattie EC; Speirs A; Gulliver F
J Hypertens; 1993 Oct; 11(10):1083-8. PubMed ID: 8258672
[TBL] [Abstract][Full Text] [Related]
10. Acute blockade of nitric oxide synthase inhibits renal vasodilation and hyperfiltration during pregnancy in chronically instrumented conscious rats.
Danielson LA; Conrad KP
J Clin Invest; 1995 Jul; 96(1):482-90. PubMed ID: 7542284
[TBL] [Abstract][Full Text] [Related]
11. Angiotensin II type 1 receptor blocker prevents atrial structural remodeling in rats with hypertension induced by chronic nitric oxide inhibition.
Okazaki H; Minamino T; Tsukamoto O; Kim J; Okada K; Myoishi M; Wakeno M; Takashima S; Mochizuki N; Kitakaze M
Hypertens Res; 2006 Apr; 29(4):277-84. PubMed ID: 16778335
[TBL] [Abstract][Full Text] [Related]
12. Comparison of effects of chronic and acute administration of NG-nitro-L-arginine methyl ester to the rat on inhibition of nitric oxide-mediated responses.
Bryant CE; Allcock GH; Warner TD
Br J Pharmacol; 1995 Apr; 114(8):1673-9. PubMed ID: 7541283
[TBL] [Abstract][Full Text] [Related]
13. Renal effects of nitric oxide synthesis inhibition in cirrhotic rats.
Atucha NM; García-Estañ J; Ramírez A; Pérez MC; Quesada T; Romero JC
Am J Physiol; 1994 Dec; 267(6 Pt 2):R1454-60. PubMed ID: 7529002
[TBL] [Abstract][Full Text] [Related]
14. Nitric oxide and prostaglandins in the prolonged effects of losartan and ramipril in hypertension.
Cachofeiro V; Maeso R; Rodrigo E; Navarro J; Ruilope LM; Lahera V
Hypertension; 1995 Aug; 26(2):236-43. PubMed ID: 7635531
[TBL] [Abstract][Full Text] [Related]
15. [Study on roles of L-arginine to nitric oxide pathway for the cardiovascular control: assessment with a new model of hypertension produced by the chronic administration of nitric oxide synthase inhibitor].
Shudo H
Hokkaido Igaku Zasshi; 1994 Jul; 69(4):967-77. PubMed ID: 7525439
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of nitric oxide synthesis does not affect ischemic preconditioning in isolated perfused rat hearts.
Weselcouch EO; Baird AJ; Sleph P; Grover GJ
Am J Physiol; 1995 Jan; 268(1 Pt 2):H242-9. PubMed ID: 7530919
[TBL] [Abstract][Full Text] [Related]
17. Nitric oxide synthase inhibition in spontaneously hypertensive rats. Systemic, renal, and glomerular hemodynamics.
Ono H; Ono Y; Frohlich ED
Hypertension; 1995 Aug; 26(2):249-55. PubMed ID: 7543452
[TBL] [Abstract][Full Text] [Related]
18. Effect of endogenous nitric oxide on cardiac systolic and diastolic function during ischemia and reperfusion in the rat isolated perfused heart.
Pabla R; Curtis MJ
J Mol Cell Cardiol; 1996 Oct; 28(10):2111-21. PubMed ID: 8930806
[TBL] [Abstract][Full Text] [Related]
19. Exogenous cGMP prevents decrease in diuresis and natriuresis induced by inhibition of NO synthesis.
Lahera V; Navarro J; Biondi ML; Ruilope LM; Romero JC
Am J Physiol; 1993 Feb; 264(2 Pt 2):F344-7. PubMed ID: 8383451
[TBL] [Abstract][Full Text] [Related]
20. Renoprotective effects of captopril in hypertension induced by nitric oxide synthase inhibition in experimental nephritis.
Uhlenius N; Tikkanen T; Miettinen A; Holthöfer H; Törnroth T; Eriksson A; Fyhrquist F; Tikkanen I
Nephron; 1999 Feb; 81(2):221-9. PubMed ID: 9933759
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
